佰仁医疗(688198) - 2021 Q3 - 季度财报

Financial Performance - The company's operating revenue for Q3 2021 was ¥58,885,573.74, representing a year-on-year increase of 13.08%[5] - The net profit attributable to shareholders for Q3 2021 was ¥14,068,918.91, an increase of 23.05% compared to the same period last year[5] - The net profit after deducting non-recurring gains and losses was ¥8,327,503.39, showing a decrease of 28.14% year-on-year[5] - The company achieved a main business income of ¥47,585,000 in Q3 2021, a year-on-year increase of 13.08% despite challenges from the pandemic and natural disasters[8] - Total operating revenue for the first three quarters of 2021 reached CNY 183,469,017.60, a significant increase from CNY 118,952,030.26 in the same period of 2020, representing a growth of approximately 54.3%[39] - Net profit for the third quarter of 2021 was CNY 40,102,904.60, down from CNY 44,179,517.39 in the same quarter of 2020, reflecting a decrease of approximately 7.8%[42] - The company reported a total comprehensive income of CNY 40,118,037.57 for the third quarter of 2021, down from CNY 44,179,517.39 in the same quarter of 2020[44] Research and Development - Research and development expenses totaled ¥15,056,317.01 for Q3 2021, a significant increase of 114.75% compared to the same period last year[7] - The ratio of R&D expenses to operating revenue was 25.57%, an increase of 12.11 percentage points year-on-year[7] - The cumulative R&D expenditure from the beginning of the year to the end of Q3 2021 was ¥37,493,961.95, accounting for 20.44% of sales revenue, an increase of 108.90% year-on-year after excluding share-based payment impacts[9] - Research and development expenses for the first three quarters of 2021 amounted to CNY 37,493,961.95, significantly higher than CNY 15,806,087.01 in 2020, marking an increase of about 137.5%[39] Assets and Liabilities - The total assets at the end of Q3 2021 were ¥962,932,755.57, reflecting a year-on-year growth of 10.50%[7] - The total assets as of September 30, 2021, amount to 962,932,755.57 RMB, an increase from 871,435,092.75 RMB at the end of 2020[30] - The total liabilities as of the latest report were CNY 18,000,906.52, down from CNY 35,616,433.04 in the previous period[37] - The total non-current liabilities were CNY 5,517,096.02, an increase from CNY 4,900,284.23 in the previous period, indicating a rise of about 12.6%[37] - The total current liabilities were reported at 30,716,148.81, indicating a robust short-term financial position[57] Shareholder Information - The total number of common shareholders at the end of the reporting period is 2,934[21] - The top shareholder, Jin Lei, holds 59,922,000 shares, representing 62.14% of the total shares[21] - The company has pledged shares amounting to 1,032,900 shares, which is 1.07% of the total shares[21] Cash Flow - Cash flow from operating activities for the first three quarters of 2021 was CNY 180,733,546.38, compared to CNY 102,893,612.07 in 2020, reflecting an increase of approximately 75.5%[45] - Operating cash inflows totaled CNY 191,050,780.90, an increase from CNY 111,966,795.34 in the previous period, reflecting a growth of approximately 70.5%[48] - Net cash flow from operating activities was CNY 55,519,532.49, up from CNY 28,128,656.19, representing an increase of approximately 97.3%[48] - Cash inflows from investment activities were CNY 936,846,891.17, slightly down from CNY 958,085,608.12, a decrease of about 2.2%[49] - Net cash flow from investment activities was -CNY 47,020,839.96, improving from -CNY 429,004,807.25, showing a significant reduction in losses[49] - Cash inflows from financing activities totaled CNY 10,782,376.80, with cash outflows of CNY 19,727,931.27, resulting in a net cash flow of -CNY 8,945,554.47[50] Expenses - Employee compensation payments increased to CNY 43,331,158.26 from CNY 27,467,218.98, marking a rise of about 57.5%[48] - Tax payments rose to CNY 20,367,642.02 from CNY 12,215,624.98, an increase of approximately 67.0%[48] - Other cash payments related to operating activities increased to CNY 57,246,430.82 from CNY 35,105,937.19, reflecting a growth of about 63.2%[48] Equity - The total equity attributable to shareholders reached CNY 946,634,199.46, an increase from CNY 837,197,093.66 in the previous period, representing a growth of approximately 13.1%[37] - The company reported a retained earnings of 110,803,839.18, showing a minor increase compared to the prior figure[57] - The company’s total equity, including minority interests, was 835,818,659.71, reflecting the overall ownership structure[57] Accounting Standards - The company has implemented the new leasing standards since January 1, 2021, affecting the measurement of lease liabilities[59] - The company’s financial statements have been adjusted for the cumulative impact of the new leasing standards without altering comparative period information[59]